AAP / AMI
Introduction

Whether you are an academic or a private laboratory, the ART-TG Integrator can help you to de-risk your cell and gene therapy projects with the aim of accelerating their industrial or clinical transfer. Depending on your needs, ART-TG can offer collaborations, customised or standardised services

Expertise
  • Gene Therapy
  • Bioprocess development and CMC (Chemistry, Manufacturing and Controls)
  • Preclinical development
Service offer
  • Lentiviral vectors bioproduction, including custom development
  • Analytical controls on vectors and cells (titrations, VCN, vector integration sites analysis, impurities, etc.)
  • Support for CMC (Chemistry, Manufacturing and Controls) and preclinical studies for clinical trial applications (EU, US).
  • Pre-clinical developments for genome-editing processes
  • In vivo preclinical studies in humanised mice
For more information, please contact